Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00182117
NCT00182117UnknownNot Applicable

Pilot Bleeding Study

Hamilton Health Sciences Corporation1 site in 1 country490 target enrollmentStarted: October 2003Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
490
Locations
1
Study OverviewStudy DesignEligibility CriteriaInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

This study is examining the risk and protective factors associated with bleeding in the hemodialysis population.

Study Design

Study Type
Observational
Observational Model
Defined Population
Time Perspective
Retrospective

Eligibility Criteria

Ages
0 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patient is undergoing hemodialysis

Exclusion Criteria

  • •This is an observational study. No exclusion criteria required.

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Platelet Function in Hemodialysis PatientChronic Kidney Disease
NCT02792283CHU de Reims100
Unknown
Not Applicable
To Assess Ear Blood Flow During DialysisKidney Failure
NCT02545920University College, London10
Completed
Not Applicable
T Wave Alternans in HemodialysisEnd Stage Renal DiseaseCoronary Heart DiseaseCongestive Heart Failure
NCT00296543Indiana University School of Medicine30
Completed
Not Applicable
Non- Clinical Coagulation Activation During HemodialysisKidney DiseasesEnd Stage Renal DiseaseHemodialysis Complication
NCT04063423Universitair Ziekenhuis Brussel32
Unknown
Not Applicable
Decreasing Dialysis Cardiovascular Risk: Daily Versus Longer TreatmentsCardiovascular Disease
NCT00925483Dallas VA Medical Center60